I'm LongbridgeAI. Here is the key information I extracted- Supporting factors include reduced earnings drag, RMB appreciation, lowered tech expectations, and continued government support, with key catalysts linked to AI hardware, US cloud capex, and property stabilization.…
UBS published a research report stating that it expects stronger performance for China equities in 2027, as MSCI China has already fallen 18% year to date, improving the risk-reward profile. The bank set its end-2027 target for MSCI China at 76, implying around 13% upside, and forecast 2027 EPS growth of 10%. Its end-2027 target for the HSI is 26,000, implying 10% upside, with projected 2027 EPS growth of 8%.
The bank noted that supporting factors include reduced earnings drag from food delivery competition and RMB appreciation, which are estimated to contribute an additional 4% to 5% to 2027 EPS growth; significantly lowered expectations for tech stocks, with the STAR 50 Index and ChiNext retreating more than 40% from their peaks; and continued government support for stable economic and equity market growth. Key catalysts include breakthroughs in mass production of key AI components such as HBM, capital expenditure guidance from US hyperscale cloud operators exceeding market concerns, stabilization in home prices driving activity improvement, and improving earnings trends in 1Q27.
The bank maintained its barbell strategy, with core allocations to AI tech hardware, banks and selected internet stocks, while also allocating part of the portfolio to oversold outbound expansion-related stocks, which are expected to perform better from 2Q27 onward. The bank is most cautious on automakers and consumer stocks.
UBS added BeOne Medicines Ltd. (ONC.US) and JD.com, Inc. (JD.US) to its most recommended model portfolio, while removing BYD COMPANY (01211.HK) -0.550 (-0.845%) Short selling $220.24M; Ratio 31.008% and BIDU-W (09888.HK) -4.450 (-5.914%) Short selling $187.05M; Ratio 27.733% .
UBS Most Recommended Model Portfolio:
Stock | Investment Rating | TP
FUYAO GLASS (03606.HK) -0.100 (-0.181%) Short selling $14.27M; Ratio 29.690% | Buy | HKD75.29
ZIJIN MIN-500 (02899.HK) +0.020 (+0.077%) Short selling $269.55M; Ratio 26.958% | Buy | HKD56
NAURA (002371.SZ) +14.470 (+2.648%) | Buy | RMB905
TENCENT (00700.HK) -10.800 (-2.766%) Short selling $1.61B; Ratio 28.312% | Buy | HKD742.6
CONTEMPORARY AMPEREX (300750.SZ) -2.300 (-0.956%) | Buy | RMB520
SYTECH (600183.SH) -2.980 (-4.858%) | Buy | RMB209
Alibaba Group Holding Limited (BABA.US) | Buy | USD207.15
CNOOC (00883.HK) -0.300 (-1.298%) Short selling $131.74M; Ratio 18.379% | Buy | HKD34.3
ZIJIN GOLD INTL (02259.HK) +1.100 (+0.936%) Short selling $21.13M; Ratio 9.811% | Buy | HKD195.9
KEDALI (002850.SZ) -3.960 (-2.457%) | Buy | RMB255
BANK OF JIANGSU (600919.SH) +0.080 (+0.595%) | Buy | RMB14
CCB (00939.HK) -0.030 (-0.281%) Short selling $391.03M; Ratio 31.432% | Buy | HKD12.01
SMIC (00981.HK) +3.580 (+7.769%) Short selling $701.46M; Ratio 12.918% | Buy | HKD102.3
CXMT (688825.SH) -1.680 (-4.382%) | Buy | RMB76
※BeOne Medicines Ltd. (ONC.US) | Buy | USD529
※JD.com, Inc. (JD.US) | Buy | USD48.17
※Newly Added
(da/u)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-11-17 12:25.) (A Shares quote is delayed for at least 15 mins.) (Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)
